Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA known ✓ | P21397 | 2/20 | 0.50 |
| ▸ | MAOB known ✓ | P27338 | 1/20 | 0.50 |
| ▸ | GLA known ✓ | P06280 | 4/20 | 0.47 |
| ▸ | GAA known ✓ | P10253 | 2/20 | 0.47 |
| ▸ | CHRM2 known ✓ | P08172 | 1/20 | 0.45 |
| ▸ | ADRA2A known ✓ | P08913 | 1/20 | 0.45 |
| ▸ | CHRM1 known ✓ | P11229 | 1/20 | 0.45 |
| ▸ | DRD1 known ✓ | P21728 | 1/20 | 0.45 |
| ▸ | ACHE known ✓ | P22303 | 1/20 | 0.45 |
| ▸ | SLC6A2 known ✓ | P23975 | 1/20 | 0.45 |
| ▸ | ADRA1A known ✓ | P35348 | 1/20 | 0.45 |
| ▸ | OPRM1 known ✓ | P35372 | 1/20 | 0.45 |
| ▸ | KCNH2 known ✓ | Q12809 | 1/20 | 0.45 |
| ▸ | PDE10A | Q9Y233 | 3/20 | 0.50 |
| ▸ | RAB9A | P51151 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.47 |
| ▸ | DHODH | Q02127 | 4/20 | 0.47 |
| ▸ | HPGD | P15428 | 3/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL642681 | 0.98 | MAOA (0.52) | PDE10AMAOAMAOBRAB9AKDM4E | |
| SCHEMBL31026536 | 0.98 | MAOA (0.52) | PDE10AMAOAMAOBRAB9AKDM4E | |
| SCHEMBL7516228 | 0.92 | PDE10A (0.56) | PDE10AMAOAMAOBKDM4EGLA | |
| Hydrochloric Acid SCHEMBL9597551 | 0.83 | PDE10A (0.63) | PDE10ARAB9AKDM4EGLAALDH1A1 | |
| Hydrochloric Acid SCHEMBL1603404 | 0.83 | PDE10A (0.63) | PDE10ARAB9AKDM4EGLAALDH1A1 | |
| SCHEMBL7534314 | 0.81 | CDK4 (0.44) | PDE10AMAOAMAOBKDM4EGLA | |
| SCHEMBL29377848 | 0.80 | PDE10A (0.66) | PDE10AMAOAKDM4EGLAALDH1A1 | |
| SCHEMBL27550242 | 0.80 | PDE10A (0.55) | PDE10AMAOAMAOBRAB9AKDM4E | |
| SCHEMBL641899 | 0.80 | PDE10A (0.66) | PDE10AMAOAKDM4EGLAALDH1A1 | |
| SCHEMBL20669570 | 0.80 | PDE10A (0.75) | PDE10AKDM4EALDH1A1SMN1; SMN2DHODH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111170994-B | Preparation method of acridine inner salt | 合肥华纳生物医药科技有限公司 | 2021-01-15 | — | — | CN | disclosed |
| CN-111170994-A | Preparation method of acridine inner salt | 合肥华纳生物医药科技有限公司 | 2020-05-19 | — | — | CN | disclosed |
| EP-0082636-B2 | Luminescent labelling materials and procedures | WELSH NAT SCHOOL OF MEDICINE (GB) | 2006-10-18 | — | — | EP | disclosed |
| US-7122671-B1 | Luminescent labelling materials and procedures | UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED (GB) | 2006-10-17 | — | — | US | disclosed |
| EP-0609885-B1 | Acridinium compounds and conjugates thereof | MOCHIDA PHARM CO LTD (JP) | 2003-04-16 | — | — | EP | disclosed |
| EP-0754178-B1 | NOVEL FUNCTIONALIZED HYDROPHILIC ACRIDINIUM ESTERS | BAYER AG (US) | 2003-01-15 | — | — | EP | disclosed |
| US-6414152-B1 | COMPOUND CAPABLE OF UNDERGOING LIGHT EMITTING REACTION IN PRESENCE OF DILUTE SOLUTION OF SODIUM HYDROXIDE AND HYDROGEN PEROXIDE, COMPRISING ACRIDINIUM CARBONYL MOIETY SUBSTITUTED WITH ARYL MOIETY HAVING ATTACHED REACTIVE GROUP | UNIVERSITY OF WALES COLLEGE OF MEDICINE OF HEATH PARK (GB) | 2002-07-02 | — | — | US | disclosed |
| EP-0617288-B1 | Long emission wavelength chemiluminescent compounds and their use in test assays | NOVARTIS AG (CH) | 2002-05-02 | — | — | EP | disclosed |
| US-6087502-A | COMPOUNDS FOR MARKING ANTIGENS OR ANTIBODIES RECEPTOR BINDING ASSAY | MOCHIDA PHARMACEUTICALS CO., LTD. (JP) | 2000-07-11 | — | — | US | disclosed |
| EP-0982298-A1 | Novel functionalized hydrophilic acridinium esters | Ciba Corning Diagnostics Corp. (US) | 2000-03-01 | — | — | EP | disclosed |
| EP-0273115-B1 | Chemiluminescent acridinium and phenanthridinium salts | ABBOTT LAB (US) | 1994-09-07 | — | — | EP | disclosed |
| EP-0609885-A1 | Acridinium compounds and conjugates thereof | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 1994-08-10 | — | — | EP | disclosed |
| WO-1993020074-A1 | HAPTENS, TRACERS, IMMUNOGENS AND ANTIBODIES FOR ACRIDINE-9-CARBOXYLIC ACIDS | ABBOTT LABORATORIES (US) | 1993-10-14 | — | — | WO | disclosed |
| US-5225584-A | Phosphonate esters and trialkylsilyl phosphonate esters | TROPIX, INC. (US) | 1993-07-06 | — | — | US | disclosed |
| EP-0511366-A1 | CHEMILUMINESCENT COMPOUNDS | BECKMAN INSTRUMENTS, INC. (US) | 1992-11-04 | — | — | EP | disclosed |
| WO-1992009580-A1 | CHEMILUMINESCENT COMPOUNDS | BECKMAN INSTRUMENTS, INC. (US) | 1992-06-11 | — | — | WO | disclosed |
| US-4946958-A | Chemiluminescent acridinium labelling compounds | THE WELSH NATIONAL SCHOOL OF MEDICINE (GB) | 1990-08-07 | — | — | US | disclosed |
| EP-0082636-B1 | LUMINESCENT LABELLING MATERIALS AND PROCEDURES | The Welsh National School of Medicine (GB) | 1988-09-14 | — | — | EP | disclosed |
| EP-0273115-A2 | Chemiluminescent acridinium and phenanthridinium salts | ABBOTT LABORATORIES (US) | 1988-07-06 | — | — | EP | disclosed |
| EP-0082636-A1 | Luminescent labelling materials and procedures | The Welsh National School of Medicine (GB) | 1983-06-29 | — | — | EP | disclosed |